The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.
about
Paneth-cell-disruption-induced necrotizing enterocolitis in mice requires live bacteria and occurs independently of TLR4 signalingIntrauterine Growth Restriction Alters Mouse Intestinal Architecture during Development.ERBB4 is over-expressed in human colon cancer and enhances cellular transformationNeurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.Transcriptional Regulation by ATOH1 and its Target SPDEF in the Intestine.ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation.Products for the treatment of inflammatory bowel disease: a patent review (2013 - 2014).ERBB4 acts as a suppressor in the development of hepatocellular carcinoma.A Role for cAMP and Protein Kinase A in Experimental Necrotizing Enterocolitis.The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1.Pathogenesis of NEC: Role of the innate and adaptive immune response.Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer.Tumor necrosis factor induces developmental stage-dependent structural changes in the immature small intestine.Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study.Plasma Neuregulin 4 Levels Are Associated with Metabolic Syndrome in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.
P2860
Q33830506-9B7B2024-499E-41D9-BDD5-2736AA4CA7B2Q35888946-A4C37B98-6782-4D85-B511-A508B89036EFQ36067899-800110F8-26A1-4B7C-AB00-90AF768FDECFQ36804007-642C5AF8-FF00-43F5-ADC3-174A7BF3D2D4Q37594953-5B869EFE-DD96-4344-9972-E906EDB27698Q37745253-7008FA8A-A61F-4B38-802D-66438A4863D4Q38461139-457AFA43-A5AC-48B5-96D4-75CD520ED7B6Q38711017-0E2316F6-3653-4144-AC10-A29127FC3554Q38726861-47D3C829-4AF5-46A2-8DDC-7185BBD424DEQ38901465-42492332-E367-4825-B859-79BCF97A663CQ39035255-0B7BF69C-48E9-4A13-AAE7-7C2452409A0BQ41839667-E4CA3C9A-B179-498F-82C4-DFCEDCF1E52FQ41977638-95AF9DFA-4D60-46D1-973D-5BEFEE1932A3Q47790647-8C470BCE-EBA4-4D29-AA48-D77EAE6382FCQ55014592-E5FCD5A1-A560-460F-B654-A20FFE2AB12A
P2860
The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.
@ast
The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.
@en
type
label
The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.
@ast
The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.
@en
prefLabel
The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.
@ast
The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis.
@en
P2093
P2860
P1476
The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis
@en
P2093
Brandon A Bell
Catherine J Hunter
Denise Al Alam
Henri R Ford
Jessica K Bernard
Larry Wang
Mark R Frey
Shannon L Castle
Steven J McElroy
P2860
P304
P356
10.1016/J.AJPATH.2014.06.015
P407
P577
2014-09-09T00:00:00Z